DUARTE, Calif.--(BUSINESS WIRE)--A significant philanthropic gift from the Campbell family of Las Vegas, NV, will establish a new endowed chair to honor City of Hope’s former Chief Medical Officer Alexandra M. Levine, M.D., M.A.C.P. The recipient of the Deana and Steve Campbell Chief Clinical Officer’s Distinguished Chair, to be recruited, will help support and advance exceptional clinical services and programs to continue Levine’s legacy of holistic, patient-centered and compassionate care.
“This Chair does more than recognize Dr. Alexandra Levine’s leadership and dedication to the mission of City of Hope,” said Robert W. Stone, president and chief executive officer of City of Hope. “It is about continuing an enduring legacy of caring for patients. It is about inspiring those who come after us to always embrace, and embody our credo – a credo modeled so beautifully by Dr. Levine: ‘There is no profit in curing the body if in the process we destroy the soul.’”
For nearly a decade at City of Hope, Levine served as City of Hope’s chief medical officer and the Dr. Norman and Melinda Payson Professor in Medicine where she embodied City of Hope’s mission of compassionate, patient-centered care. Levine was responsible for programs encompassing quality of service, patient safety, clinical research, clinical information management and professional education. She served as a primary liaison with City of Hope physicians to promote collaboration across disciplines and to ensure world-class care.
Levine is also well known in the medical community for her compassion and empathy, something cancer survivor Deana Campbell has experienced firsthand. Levine was a constant presence during Campbell’s battle with lymphoma in 2009, and again in 2012. Today, Campbell is cancer free. She praises Levine for providing comfort and healing during the most difficult time in her life.
“Hers was the first face I saw when I came to City of Hope,” said Campbell, who lost her father to the disease seven years prior to receiving her own devastating diagnosis. “She walked over and embraced me with such a big hug. I was in the arms of someone who made me feel safe, who was wildly compassionate and kept telling me this is our fight, not my fight.”
To celebrate Levine’s retirement from City of Hope, Campbell and her husband Steve wanted to acknowledge her compassionate care and honor her philanthropically. The announcement of the chair was a surprise to Levine, and a touching tribute, she said, as she begins the next chapter in her life.
“This is deeply meaningful and I cannot tell you how proud and humbled I am by this gracious gift,” Levine said. “The Campbells are now a part of the amazing work that City of Hope does, in a very official way. Their generosity and beauty as a family is something I will never forget. I am so grateful.”
“An endowment of this nature at the C-suite level is fairly uncommon and is indicative of the value the Campbell family places on Dr. Levine’s legacy,” said Kristin Bertell, chief philanthropy officer at City of Hope. “In this season of peace and goodwill, the Campbell’s benevolence preserves Dr. Levine’s imprint and contributions to City of Hope for many years to come. She will forever be grafted into our organizational DNA. We are so thankful to her for years of service, and to the Campbell family for their generosity and gratitude.”
About City of Hope
City of Hope is an independent research and treatment center for cancer, diabetes and other life-threatening diseases. Designated as one of only 47 comprehensive cancer centers, the highest recognition bestowed by the National Cancer Institute, City of Hope is also a founding member of the National Comprehensive Cancer Network, with research and treatment protocols that advance care throughout the world. City of Hope is located in Duarte, California, just northeast of Los Angeles, with community clinics throughout Southern California. It is ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report. Founded in 1913, City of Hope is a pioneer in the fields of bone marrow transplantation, diabetes and numerous breakthrough cancer drugs based on technology developed at the institution.